Clofarabine, cytarabine, and mitoxantrone in refractory/relapsed acute myeloid leukemia: High response rates and effective bridge to allogeneic hematopoietic stem cell transplantation

Author:

Gill Harinder1ORCID,Yim Rita1,Pang Herbert H.2,Lee Paul1,Chan Thomas S. Y.1,Hwang Yu‐Yan1,Leung Garret M. K.1,Ip Ho‐Wan3,Leung Rock Y. Y.3,Yip Sze‐Fai4,Kho Bonnie5,Lee Harold K. K.6,Mak Vivien6,Chan Chi‐Chung7,Lau June S. M.7,Lau Chi‐Kuen8,Lin Shek‐Yin9,Wong Raymond S. M.10,Li Wa11,Ma Edmond S. K.12,Li Jun1314,Panagiotou Gianni141516,Sim Joycelyn P. Y.1,Lie Albert K. W.1,Kwong Yok‐Lam1ORCID

Affiliation:

1. Department of Medicine The University of Hong Kong Hong Kong SAR China

2. School of Public Health The University of Hong Kong Hong Kong SAR China

3. Department of Pathology Queen Mary Hospital Hong Kong SAR China

4. Department of Medicine Tuen Mun Hospital Hong Kong SAR China

5. Department of Medicine Pamela Youde Nethersole Eastern Hospital Hong Kong SAR China

6. Department of Medicine Princess Margaret Hospital Hong Kong SAR China

7. Department of Medicine Queen Elizabeth Hospital Hong Kong SAR China

8. Department of Medicine Tseung Kwan O Hospital Hong Kong SAR China

9. Department of Medicine United Christian Hospital Hong Kong SAR China

10. Department of Medicine and Therapeutics Prince of Wales Hospital Hong Kong SAR China

11. Department of Clinical Oncology Prince of Wales Hospital Hong Kong SAR China

12. Department of Pathology Hong Kong Sanatorium and Hospital Hong Kong SAR China

13. Department of Infectious Diseases and Public Health The City University of Hong Kong Hong Kong SAR China

14. School of Biological Sciences The University of Hong Kong Hong Kong SAR China

15. Department of Microbiology Li Ka Shing Faculty of Medicine The University of Hong Kong Hong Kong SAR China

16. Department of Systems Biology and Bioinformatics Leibniz Institute for Natural Product Research and Infection Biology Hans Knöll Institute (HKI) Jena Germany

Publisher

Wiley

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3